Miguel Montalvo
Instructor Miguel Montalvo
Product Id 600934
Duration 90 Minutes
Version Recorded
Original Price $295
Special Offer Price $10
Refund Policy
Access recorded version only for one participant; unlimited viewing for 6 months

Effective Application of CAPA using a Risk-Based Approach

Overview:

It is imperative to apply CAPA at a level commensurate with the risk to the product quality resulting from the failure being addressed. A formal CAPA process must not be applied without a risk assessment of the event/system failure and the level of detail/depth during the investigation must correlate with the risk level to the product quality also considering the probability of re-occurrence and the detection capabilities if the event or failure should occur again. This session will address how to apply different levels of the CAPA process corresponding to the risk being addressed.

Why should you attend: The lack of or ineffective CAPA Implementation is still one of the most common issues found by the FDA during their inspections due to the lack of structure and incorrect approach used by the companies. Many of them are applying CAPA to every deviation as just a paper completion process without understanding the true meaning of the CAPA concept.

Course Modules & Content Details:

  • Elements of a CAPA procedure:
    • Definitions
    • Systems to trigger CAPA:Procedure deviations, OOS, Internal/External Audits, Documentation errors, Customer Complaint system, Reworks/Reprocessing data, others.
    • Criteria to apply CAPA - reoccurrence, criticality, impact on product quality or process controls
    • Determination of a risk-based categorization for each CAPA to address the level of detail/formality of the evaluation process
  • Analysis of the CAPA and How to Apply Quality Risk Management:
    • Corrective - Root cause analysis with corrective action to prevent recurrence - establish detail based on the risk-based levels
    • Preventive action to prevent initial occurrence - establish detail based on the risk-based levels
  • How to identify corrective and preventive actions
  • How to verify/validate that the corrective /preventive actions have been effective applying the risk levels to determine the extent of the verification
  • Communication - management reports

Who Will Benefit:
  • Manufacturing
  • R&D
  • Quality
  • Validation
  • Engineering
  • Top Management

Speaker Profile
Miguel Montalvo, B.S. Chem. Eng., MBA, President, Expert Validation Consulting, has over twenty-eight years of professional/management experience in positions of increasing responsibility in the areas of Quality, Validations and Technical Services within the traditional pharmaceutical, OTC Drugs, cosmetics, dietary supplements, biotechnology and medical device industries including extensive expertise on development and implementation of quality functional procedures (QA/QC), Quality Systems, GMP/QSR compliance audits (internal, supplier, external audits), remediation projects with companies on consent decrees, handling of non-conformances (OOS, investigations and deviations), Process/Cleaning/Computer Systems/Equipment/Facility validations, Change Control, CAPA, international GMP compliance, Calibrations, Risk Management, operational compliance assessments/Gap Analysis and start-up of manufacturing facilities.

He is a well-recognized international speaker on GMP Compliance, Validation and Quality related topics for organizations such as IVT, PDA-TRI, CfPIE and Barnett International and his articles/papers have been published in the American Pharmaceutical Review and the Journal of Validation Technology publications and have been published as an author of specific chapters in several design/quality/validation related internationally-recognized reference books. He is a member of the Journal of Validation Technology editorial board and of the PDA Annual Program Committee for their Annual meetings.

Sign Up for Our Newsletter